Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Goff

Showing results (491-500 of 527) with videos related to

Pageof 53
Sort By:
Journal of the American College of Cardiology|January 22, 2016
Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk AssessmentJoseph Yeboah, Rebekah Young, Robyn L McClelland, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
High prevalence of CNS-directed autoantibodies in patients with schizophreniaKatlyn Nemani, Jillian R Jaycox, Ugur Akcan, et al.
JAMA Network Open|June 30, 2026
Sodium-Glucose Cotransporter 2 Inhibitors and Dementia Risk in Patients With Psychiatric DisordersDavid T Liebers, Tianshe He, Rebecca A Betensky, et al.
Plos Medicine|March 21, 2018
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant dataKunal N Karmali, Donald M Lloyd-Jones, Joep van der Leeuw, et al.
JAMA|June 29, 2000
Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) TrialR V Luepker, J M Raczynski, S Osganian, et al.
Diabetes Care|March 6, 2014
Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trialKaren L Margolis, Patrick J O'Connor, Timothy M Morgan, et al.
The American Journal of Cardiology|July 12, 2007
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods, John B Buse, J Thomas Bigger, et al.
Obesity (Silver Spring, Md.)|April 12, 2023
Contribution of social, behavioral, and contextual exposures to Black-White disparities in incident obesity: The CARDIA studyChristopher Song, Michael P Bancks, Kara M Whitaker, et al.
Psychiatry Research. Neuroimaging|April 15, 2021
Effect of citalopram on hippocampal volume in first-episode schizophrenia: Structural MRI results from the DECIFER trialWei Qi, Esther Blessing, Chenxiang Li, et al.
Brain, Behavior, & Immunity - Health|July 18, 2024
Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorderKatlyn Nemani, Livia De Picker, Faith Dickerson, et al.
Pageof 53

Showing results (491-500 of 527) with videos related to

Sort By:
Pageof 53
Journal of the American College of Cardiology|January 22, 2016
Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk AssessmentJoseph Yeboah, Rebekah Young, Robyn L McClelland, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
High prevalence of CNS-directed autoantibodies in patients with schizophreniaKatlyn Nemani, Jillian R Jaycox, Ugur Akcan, et al.
JAMA Network Open|June 30, 2026
Sodium-Glucose Cotransporter 2 Inhibitors and Dementia Risk in Patients With Psychiatric DisordersDavid T Liebers, Tianshe He, Rebecca A Betensky, et al.
Plos Medicine|March 21, 2018
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant dataKunal N Karmali, Donald M Lloyd-Jones, Joep van der Leeuw, et al.
JAMA|June 29, 2000
Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) TrialR V Luepker, J M Raczynski, S Osganian, et al.
Diabetes Care|March 6, 2014
Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trialKaren L Margolis, Patrick J O'Connor, Timothy M Morgan, et al.
The American Journal of Cardiology|July 12, 2007
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods, John B Buse, J Thomas Bigger, et al.
Obesity (Silver Spring, Md.)|April 12, 2023
Contribution of social, behavioral, and contextual exposures to Black-White disparities in incident obesity: The CARDIA studyChristopher Song, Michael P Bancks, Kara M Whitaker, et al.
Psychiatry Research. Neuroimaging|April 15, 2021
Effect of citalopram on hippocampal volume in first-episode schizophrenia: Structural MRI results from the DECIFER trialWei Qi, Esther Blessing, Chenxiang Li, et al.
Brain, Behavior, & Immunity - Health|July 18, 2024
Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorderKatlyn Nemani, Livia De Picker, Faith Dickerson, et al.
Pageof 53